Procurement of storage and stability services to maintain BARDA�s supply of Live Attenuated Influenza Virus Master and Working Seed Lots
Health and Human Services (all) · BARDA - ASPR / DAAPPO / BARDA DCMA
Capture briefs (a one-page, shareable copy of this page) are part of Pro. The CSV here holds the notice, its timeline and past awards.
Where this opportunity stands
Every notice posted under solicitation 75A50125P00002 in this department, oldest first.
- Mar 17, 2025 · this noticeAward NoticeMEDIMMUNE LLC · $84K
Next steps for this stage
Standard steps for the notice type; not advice about this buyer.
- Note the winner and the end of the period of performance for the recompete.
- Follow the agency to see the next notice for this work.
What the notice says
Biomedical Advanced Research and Development Authority (BARDA), within the Administration for Strategic Preparedness and Response (ASPR) at the U.S. Department of Health and Human Services (HHS) awarded a Firm Fixed Price sole source purchase order with Medimmune, LLC, located at One Medimmune Way, Gaithersburg, Maryland 20878-4028 for the procurement of storage and stability services to maintain BARDA�s supply of Live Attenuated Influenza Virus Master and Working Seed Lots. The government awarded a sole source purchase order to MedImmune, LLC., per FAR 6.302?1, as no other source would satisf… (show all)
y agency requirements. MedImmune was awarded an indefinite-delivery, indefinite-quantity (ID/IQ) contract for the acquisition of Medical Countermeasures (MCMs) for Pandemic Influenza in 2016. Under that contract, task orders were issued to produce cGMP Influenza Vaccine Master and Working Seed Lots, including storage and stability testing of the seed lots. Since the IDIQ award, MedImmune has been performing storage and stability testing of the Live Attenuated Master and Working Seed Lots. The seed lots are used for the production of clinical trial material or commercial-scale drug substances for pandemic preparedness. Storage and stability testing of the seed lots is required to ensure they remain within the specification of this requirement.
Who won similar work
8 award notices on SAM.gov in the last 24 months. Match: Same office, same NAICS 541714.
| Winner | Awards | Value | Last |
|---|---|---|---|
| ALBERT B. SABIN VACCINE INSTITUTE, INC. | 1 | $1.0B | May 7, 2026 |
| KALEO, INC. | 1 | $340.9M | Sep 30, 2026 |
| CIDARA THERAPEUTICS INC | 1 | $339.2M | Oct 14, 2025 |
| VERICEL CORPORATION · $VCEL | 1 | $196.9M | Apr 2, 2026 |
| RAFA LABORATORIES LTD | 1 | $186.0M | Oct 1, 2025 |
| Flosonics Medical LLC | 1 | $99.7M | Jun 5, 2026 |
| OSIVAX Paris 8 �le-de-France 75008 FRA | 1 | $98.6M | Oct 14, 2025 |
| ISOLA THERAPEUTICS INC | 1 | $7.5M | Apr 27, 2026 |
Value counts single-winner awards. "Shared" awards are multiple-award contracts that list every winner with the same total ceiling; that ceiling is not one company's win, so it is not added in.
- Sep 30, 2026KALEO, INC.$340.9MRFP - 2-PAM Autoinjectors for Project Bioshield (PBS)
- Jun 5, 2026Flosonics Medical LLC$99.7MBiomedical Advanced Research and Development Authority (BARDA) Broad Agency Announcement (BAA)
- May 7, 2026ALBERT B. SABIN VACCINE INSTITUTE, INC.$1.0BStrategic Marburg Advanced Research and Development, Preparedness, Registration, Evaluation and Procurement (SMART-PREP)
- Apr 27, 2026ISOLA THERAPEUTICS INC$7.5MBARDA DRIVe EZ-BAA (EZBAA - 22-100-SOL-00003)
- Apr 2, 2026VERICEL CORPORATION$196.9MNonSurgical Debridement
- Oct 14, 2025OSIVAX Paris 8 �le-de-France 75008 FRA$98.6MClinical Proof of Concept of OVX836, a single-shot broadly protective Influenza A vaccine for immediate protection against emerging pandemic strains
- Oct 14, 2025CIDARA THERAPEUTICS INC$339.2MDevelopment of CD388 as a long-lasting prophylactic anti-viral option for protection against the health impacts caused by influenza
- Oct 1, 2025RAFA LABORATORIES LTD$186.0MDevelopment Of a Concentrated Tranexamic Acid (TXA) Intramuscular Injection
Competitive landscape
For the 8 most frequent past winners above. Lobbying is matched by the company's exact name or exact ticker; agencies are as named on the filings.
- 2 of these past winners lobbied Health & Human Services, Dept of (HHS) since 2024 (7 filings)
- 2 of their lobbyists list a past Health & Human Services, Dept of (HHS) job
- No corporate PAC money from them to the overseeing committees since 2024
- 0 foreign-agent (FARA) registrations
Policy around it
Bills the past winners named while lobbying this agency's issues, rules from the department, and executive orders that name the agency, last 12 months.
- 0 bills named on the past winners' lobbying filings
- 252 rules from the department in the last 12 months
- 0 executive orders naming the agency in the last 12 months
Market
For past winners matched exactly to a listed company. Insider trades are open-market buys and sells (Form 4) in the last 90 days, shown as facts; our own study found insiders do not reliably buy ahead of awards.
- 1 of the past winners are listed companies
- 0 insider buys and 0 insider sells at them in the last 90 days
Sources: SAM.gov notices and award notices; Senate LDA lobbying filings; FEC filings; FARA; Federal Register; congress.gov; SEC Form 4. Every row above links to its record.
Companies are matched to tickers by exact name only. A company we could not match shows no market rows; that is a miss, not a finding.